{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:33:35Z","timestamp":1794893615014,"version":"4.9.1"},"reference-count":56,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiplexed immune cell profiling of the tumor microenvironment (TME) in cancer has improved our understanding of cancer immunology, but complex spatial analyses of tumor-immune interactions in lymphoma are lacking. Here, we used imaging mass cytometry (IMC) on 33 cases of diffuse large B-cell lymphoma (DLBCL) to characterize tumor and immune cell architecture and correlate it to clinicopathological features such as cell of origin, gene mutations, and responsiveness to chemotherapy. To understand the poor response of DLBCL to immune checkpoint inhibitors (ICI), we compared our results to IMC data from Hodgkin lymphoma, a cancer highly responsive to ICI, and observed differences in the expression of PD-L1, PD-1, and TIM-3. We created a spatial classification of tumor cells and identified tumor-centric subregions of immune activation, immune suppression, and immune exclusion within the topology of DLBCL. Finally, the spatial analysis allowed us to identify markers such as CXCR3, which are associated with penetration of immune cells into immune desert regions, with important implications for engineered cellular therapies. This is the first study to integrate tumor mutational profiling, cell of origin classification, and multiplexed immuno-phenotyping of the TME into a spatial analysis of DLBCL at the single-cell level. We demonstrate that, far from being histopathologically monotonous, DLBCL has a complex tumor architecture, and that changes in tumor topology can be correlated with clinically relevant features. This analysis identifies candidate biomarkers and therapeutic targets such as TIM-3, CCR4, and CXCR3 that are relevant for combination treatment strategies in immuno-oncology and cellular therapies.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022007493","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T14:52:24Z","timestamp":1654699944000},"page":"4675-4690","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":54,"title":["Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4981-1651","authenticated-orcid":false,"given":"Anthony R.","family":"Colombo","sequence":"first","affiliation":[{"name":"1Department of Population and Public Health Sciences & Division of Biostatistics, Keck School of Medicine of University of Southern California, Los Angeles, CA;"},{"name":"2Samuel Oschin Comprehensive Cancer Institute, and"},{"name":"3Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8872-4588","authenticated-orcid":false,"given":"Monirath","family":"Hav","sequence":"additional","affiliation":[{"name":"2Samuel Oschin Comprehensive Cancer Institute, and"},{"name":"3Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Singh","sequence":"additional","affiliation":[{"name":"4USC Michelson Center for Convergent Biosciences and Department of Biological Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4877-4358","authenticated-orcid":false,"given":"Alexander","family":"Xu","sequence":"additional","affiliation":[{"name":"2Samuel Oschin Comprehensive Cancer Institute, and"},{"name":"3Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Gamboa","sequence":"additional","affiliation":[{"name":"2Samuel Oschin Comprehensive Cancer Institute, and"},{"name":"3Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tucker","family":"Lemos","sequence":"additional","affiliation":[{"name":"2Samuel Oschin Comprehensive Cancer Institute, and"},{"name":"3Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Gerdtsson","sequence":"additional","affiliation":[{"name":"4USC Michelson Center for Convergent Biosciences and Department of Biological Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3753-405X","authenticated-orcid":false,"given":"Denaly","family":"Chen","sequence":"additional","affiliation":[{"name":"5Department of Medicine, University of Southern California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Houldsworth","sequence":"additional","affiliation":[{"name":"6Cancer Genetics, Inc, Rutherford, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Shaknovich","sequence":"additional","affiliation":[{"name":"6Cancer Genetics, Inc, Rutherford, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6782-8361","authenticated-orcid":false,"given":"Tomohiro","family":"Aoki","sequence":"additional","affiliation":[{"name":"7Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia;"},{"name":"8Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Chong","sequence":"additional","affiliation":[{"name":"7Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Takata","sequence":"additional","affiliation":[{"name":"7Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Chavez","sequence":"additional","affiliation":[{"name":"7Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Steidl","sequence":"additional","affiliation":[{"name":"7Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia;"},{"name":"8Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hicks","sequence":"additional","affiliation":[{"name":"4USC Michelson Center for Convergent Biosciences and Department of Biological Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2629-4505","authenticated-orcid":false,"given":"Peter","family":"Kuhn","sequence":"additional","affiliation":[{"name":"4USC Michelson Center for Convergent Biosciences and Department of Biological Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8083-9639","authenticated-orcid":false,"given":"Imran","family":"Siddiqi","sequence":"additional","affiliation":[{"name":"9Department of Pathology, University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7472-822X","authenticated-orcid":false,"given":"Akil","family":"Merchant","sequence":"additional","affiliation":[{"name":"2Samuel Oschin Comprehensive Cancer Institute, and"},{"name":"3Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"issue":"12","key":"2022081215221485700_B1","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood."},{"issue":"22","key":"2022081215221485700_B2","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med."},{"issue":"5","key":"2022081215221485700_B3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood."},{"issue":"12","key":"2022081215221485700_B4","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1093\/annonc\/mdy450","article-title":"Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue","volume":"29","author":"Ciavarella","year":"2018","journal-title":"Ann Oncol."},{"issue":"5","key":"2022081215221485700_B5","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2011-03-345272","article-title":"Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment","volume":"118","author":"Alizadeh","year":"2011","journal-title":"Blood."},{"issue":"3","key":"2022081215221485700_B6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1200\/JCO.2001.19.3.720","article-title":"Cd4+ T-cell immune response to large B-cell non-Hodgkin\u2019s lymphoma predicts patient outcome","volume":"19","author":"Ansell","year":"2001","journal-title":"J Clin Oncol."},{"issue":"2","key":"2022081215221485700_B7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00428-013-1519-9","article-title":"The density of CD8+ T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone","volume":"464","author":"Rajnai","year":"2014","journal-title":"Virchows Arch."},{"issue":"2","key":"2022081215221485700_B8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10428190701824536","article-title":"Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis","volume":"49","author":"Lee","year":"2008","journal-title":"Leuk Lymphoma."},{"issue":"3","key":"2022081215221485700_B9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3324\/haematol.2014.110189","article-title":"Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP","volume":"100","author":"Coutinho","year":"2015","journal-title":"Haematologica."},{"issue":"8","key":"2022081215221485700_B10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1182\/bloodadvances.2016000885","article-title":"Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified","volume":"1","author":"Nakayama","year":"2017","journal-title":"Blood Adv."},{"issue":"2","key":"2022081215221485700_B11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3324\/haematol.2015.124008","article-title":"Tumor-associated macrophages in diffuse large B-cell lymphoma","volume":"100","author":"Kridel","year":"2015","journal-title":"Haematologica."},{"issue":"6","key":"2022081215221485700_B12","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.cell.2018.08.039","article-title":"A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging","volume":"174","author":"Keren","year":"2018","journal-title":"Cell."},{"issue":"2","key":"2022081215221485700_B13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s43018-020-0026-6","article-title":"Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer","volume":"1","author":"Ali","year":"2020","journal-title":"Nat Can."},{"issue":"7796","key":"2022081215221485700_B14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41586-019-1876-x","article-title":"The single-cell pathology landscape of breast cancer","volume":"578","author":"Jackson","year":"2020","journal-title":"Nature."},{"key":"2022081215221485700_B15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.07.010","article-title":"Deep profiling of mouse splenic architecture with CODEX multiplexed imaging","volume":"174","author":"Goltsev","year":"2018","journal-title":"Cell."},{"issue":"3","key":"2022081215221485700_B16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat Rev Immunol."},{"issue":"1","key":"2022081215221485700_B17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood."},{"issue":"15","key":"2022081215221485700_B18","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-Cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med."},{"issue":"5","key":"2022081215221485700_B19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes [published correction appears in Nat Med. 2018;24(8):1292]","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med."},{"issue":"1","key":"2022081215221485700_B20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12885-019-5466-y","article-title":"The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma: a\u00a0meta-analysis","volume":"19","author":"Qiu","year":"2019","journal-title":"BMC Cancer."},{"issue":"6","key":"2022081215221485700_B21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41379-018-0193-5","article-title":"PD-1\/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program","volume":"32","author":"Li","year":"2019","journal-title":"Mod Pathol."},{"issue":"18","key":"2022081215221485700_B22","doi-asserted-by":"crossref","first-page":"e6369","DOI":"10.1097\/MD.0000000000006369","article-title":"Prognostic significance of PD-L1 in solid tumor: an updated meta-analysis","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine."},{"issue":"19","key":"2022081215221485700_B23","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","article-title":"Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma","volume":"126","author":"Kiyasu","year":"2015","journal-title":"Blood."},{"issue":"4","key":"2022081215221485700_B24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med."},{"issue":"9","key":"2022081215221485700_B25","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S1470-2045(16)30167-X","article-title":"Nivolumab for classical Hodgkin\u2019s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial","volume":"17","author":"Younes","year":"2016","journal-title":"Lancet Oncol."},{"issue":"31","key":"2022081215221485700_B26","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1200\/JCO.2016.67.3467","article-title":"Programmed death-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure","volume":"34","author":"Armand","year":"2016","journal-title":"J Clin Oncol."},{"issue":"6","key":"2022081215221485700_B27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1200\/JCO.18.00766","article-title":"Nivolumab for relapsed\/refractory diffuse large B-cell lymphoma in patients ineligible for or having failed autologous transplantation: a single-arm, phase II study","volume":"37","author":"Ansell","year":"2019","journal-title":"J Clin Oncol."},{"issue":"4","key":"2022081215221485700_B28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.2869","article-title":"Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry","volume":"11","author":"Giesen","year":"2014","journal-title":"Nat Methods."},{"issue":"3","key":"2022081215221485700_B29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","article-title":"Single-cell transcriptome analysis reveals disease-defining t-cell subsets in the tumor microenvironment of classic hodgkin lymphoma","volume":"10","author":"Aoki","year":"2020","journal-title":"Cancer Discov."},{"issue":"5","key":"2022081215221485700_B30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cels.2018.02.010","article-title":"Compensation of signal spillover in suspension and imaging mass cytometry","volume":"6","author":"Chevrier","year":"2018","journal-title":"Cell Syst."},{"key":"2022081215221485700_B31","author":"Zanotelli"},{"issue":"1","key":"2022081215221485700_B32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/1471-2105-9-482","article-title":"CellProfiler Analyst: data exploration and analysis software for complex image-based screens","volume":"9","author":"Jones","year":"2008","journal-title":"BMC Bioinformatics."},{"issue":"3","key":"2022081215221485700_B33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cmet.2018.11.014","article-title":"A map of human type 1 diabetes progression by imaging mass cytometry","volume":"29","author":"Damond","year":"2019","journal-title":"Cell Metab."},{"issue":"12","key":"2022081215221485700_B34","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41592-019-0582-9","article-title":"ilastik: interactive machine learning for (bio)image analysis","volume":"16","author":"Berg","year":"2019","journal-title":"Nat Methods"},{"issue":"1","key":"2022081215221485700_B35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","article-title":"Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis","volume":"162","author":"Levine","year":"2015","journal-title":"Cell."},{"issue":"9","key":"2022081215221485700_B36","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nmeth.4391","article-title":"histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data","volume":"14","author":"Schapiro","year":"2017","journal-title":"Nat Methods."},{"issue":"1","key":"2022081215221485700_B37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s42003-019-0415-5","article-title":"diffcyt: differential discovery in high-dimensional cytometry via high-resolution clustering","volume":"2","author":"Weber","year":"2019","journal-title":"Commun Biol."},{"issue":"1","key":"2022081215221485700_B38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41592-018-0254-1","article-title":"A test metric for assessing single-cell RNA-seq batch correction","volume":"16","author":"B\u00fcttner","year":"2019","journal-title":"Nat Methods."},{"issue":"103","key":"2022081215221485700_B39","doi-asserted-by":"crossref","first-page":"20141153","DOI":"10.1098\/rsif.2014.1153","article-title":"Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer","volume":"12","author":"Yuan","year":"2015","journal-title":"J R Soc Interface."},{"issue":"4","key":"2022081215221485700_B40","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1309\/AJCPPHMZ6VHF0WQV","article-title":"p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single institutional clinicopathologic study","volume":"141","author":"Xie","year":"2014","journal-title":"Am J Clin Pathol."},{"issue":"4","key":"2022081215221485700_B41","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1158\/2326-6066.CIR-18-0439","article-title":"Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL","volume":"7","author":"Xu-Monette","year":"2019","journal-title":"Cancer Immunol Res."},{"issue":"2","key":"2022081215221485700_B42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/art.27217","article-title":"Proliferative remodeling of the spatial organization of human superficial chondrocytes distant from focal early osteoarthritis","volume":"62","author":"Rolauffs","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"10","key":"2022081215221485700_B43","doi-asserted-by":"crossref","first-page":"e0140442","DOI":"10.1371\/journal.pone.0140442","article-title":"Spatial distribution patterns in the very rare and species-rich Picea chihuahuana tree community (Mexico) [published correction appears in Plos One. 2015;10(11):e0143899","volume":"10","author":"Wehenkel","year":"2015","journal-title":"PLoS One."},{"issue":"14","key":"2022081215221485700_B44","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1200\/JCO.2017.76.0793","article-title":"Nivolumab for relapsed\/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 Trial [published correction appears in J Clin Oncol. 2018;36(26):2748]","volume":"36","author":"Armand","year":"2018","journal-title":"J Clin Oncol."},{"issue":"5","key":"2022081215221485700_B45","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nbt.4091","article-title":"Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors","volume":"36","author":"Haghverdi","year":"2018","journal-title":"Nat Biotechnol."},{"issue":"11","key":"2022081215221485700_B46","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41590-020-0769-3","article-title":"The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies","volume":"21","author":"Kumagai","year":"2020","journal-title":"Nat Immunol."},{"issue":"6","key":"2022081215221485700_B47","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1158\/2159-8290.CD-20-0839","article-title":"Clinical and Biological Subtypes of B-cell lymphoma revealed by microenvironmental signatures","volume":"11","author":"Kotlov","year":"2021","journal-title":"Cancer Discov."},{"issue":"4","key":"2022081215221485700_B48","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-18-1090","article-title":"Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition","volume":"9","author":"Ennishi","year":"2019","journal-title":"Cancer Discov."},{"issue":"10","key":"2022081215221485700_B49","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.ccell.2021.08.011","article-title":"The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma","volume":"39","author":"Steen","year":"2021","journal-title":"Cancer Cell."},{"issue":"6","key":"2022081215221485700_B50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","article-title":"Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group: part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat Pathol."},{"issue":"23","key":"2022081215221485700_B51","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1073\/pnas.1621280114","article-title":"CCR8+FOXp3+ Treg cells as master drivers of immune regulation","volume":"114","author":"Barsheshet","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"issue":"7","key":"2022081215221485700_B52","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res."},{"issue":"21","key":"2022081215221485700_B53","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1158\/0008-5472.CAN-04-2059","article-title":"CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease","volume":"64","author":"Mullins","year":"2004","journal-title":"Cancer Res."},{"issue":"4","key":"2022081215221485700_B54","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1053\/j.gastro.2009.10.057","article-title":"Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer","volume":"138","author":"Mlecnik","year":"2010","journal-title":"Gastroenterology."},{"issue":"21","key":"2022081215221485700_B55","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.18632\/oncotarget.26771","article-title":"The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma","volume":"10","author":"Chen","year":"2019","journal-title":"Oncotarget."},{"issue":"22","key":"2022081215221485700_B56","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","article-title":"Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma","volume":"130","author":"Carey","year":"2017","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/16\/4675\/1913241\/advancesadv2022007493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/16\/4675\/1913241\/advancesadv2022007493.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T16:17:51Z","timestamp":1700669871000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/16\/4675\/485486\/Single-cell-spatial-analysis-of-tumor-immune"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":56,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022,8,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007493","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.02.01.21250775","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]}}}